Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors
- 16 December 2003
- journal article
- research article
- Published by Springer Science and Business Media LLC in The Pharmacogenomics Journal
- Vol. 4 (1), 40-48
- https://doi.org/10.1038/sj.tpj.6500220
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Pharmacogenetics of oral anticoagulantsPharmacogenetics, 2003
- Pharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarinThe Pharmacogenomics Journal, 2003
- Interindividual variability in sensitivity to warfarin-Nature or nurture?Clinical Pharmacology & Therapeutics, 2001
- Characteristics of Anticoagulant Therapy and Comorbidity Related to OveranticoagulationThrombosis and Haemostasis, 2001
- Oral AnticoagulantsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1998
- Human P450 metabolism of warfarinPharmacology & Therapeutics, 1997
- The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with WarfarinAnnals of Internal Medicine, 1996
- Clinically Important Drug Interactions with AnticoagulantsClinical Pharmacokinetics, 1996
- Interactions of Warfarin with Drugs and FoodAnnals of Internal Medicine, 1994
- Anticoagulant-related bleeding: Clinical epidemiology, prediction, and preventionAmerican Journal Of Medicine, 1993